Source link : https://news.google.com/rss/articles/CBMid0FVX3lxTE93Tm94aGhsdFAwLXJiMXc2em9JMUlBLWVSZ2JXdy1TM2REaEs3eHVFakJuSU1EOU5wSVhrN3hZTDZLWGZ4TC1Icy1TcjFqMmlVcS1HNWRFUVplTFlWa3NMcnhjSklaN0tlZVo1cnpybzBpREZWdklF?oc=5
Author :
Publish date : 2013-10-08 07:00:00
Copyright for syndicated content belongs to the linked Source.
Formycon receives EU approval for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand names AHZANTIVE® and Baiama
Source link : http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=678e3025715d44a5a04bd3afa3062904&url=https%3A%2F%2Fpipelinereview.com%2Fformycon-receives-eu-approval-for-fyb203-aflibercept-a-biosimilar-to-eylea-under-the-brand-names-ahzantive-and-baiama%2F&c=17630121949157022097&mkt=de-de Author : Publish date : 2025-01-20 00:17:00 Copyright for syndicated content belongs to the linked Source.